Juan García-Revilla

About Juan García-Revilla

Juan García-Revilla, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Universidad de Sevilla, specializes in the field of Neurociencia, Neurodegeneración, Enfermedad de Parkinson.

His recent articles reflect a diverse array of research interests and contributions to the field:

Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth

Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain

GALECTIN-3 SHAPES TOXIC ALPHA-SYNUCLEIN AGGREGATES IN PARKINSON´ S DISEASE

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

The absence of caspase-8 in the dopaminergic system leads to mild autism-like behavior

Juan García-Revilla Information

University

Position

___

Citations(all)

767

Citations(since 2020)

733

Cited By

200

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

12

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Juan García-Revilla Skills & Research Interests

Neurociencia

Neurodegeneración

Enfermedad de Parkinson

Top articles of Juan García-Revilla

Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth

bioRxiv

2023

Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain

Neuropathology and Applied Neurobiology

2024/2

GALECTIN-3 SHAPES TOXIC ALPHA-SYNUCLEIN AGGREGATES IN PARKINSON´ S DISEASE

IBRO Neuroscience Reports

2023/10/1

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease

Acta Neuropathologica

2023/7

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

Acta Neuropathologica

2023/4

APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

2022/9/24

Juan García-Revilla
Juan García-Revilla

H-Index: 6

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

2022/7/20

The absence of caspase-8 in the dopaminergic system leads to mild autism-like behavior

Frontiers in Cell and Developmental Biology

2022/4/5

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors

The Journal of Clinical Investigation

2022/3/15

Inflammatory bowel disease induces α-synuclein aggregation in gut and brain

bioRxiv

2022/1/28

Inflammatory animal models of Parkinson’s disease

2022/1/1

Juan García-Revilla
Juan García-Revilla

H-Index: 6

Galectin-3 deletion reduces LPS and acute colitis-induced pro-inflammatory microglial activation in the ventral mesencephalon

Frontiers in Pharmacology

2021

Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour

Progress in Neuro-Psychopharmacology and Biological Psychiatry

2021/1/10

Hyperinflammation and fibrosis in severe COVID-19 patients: galectin-3, a target molecule to consider

Frontiers in Immunology

2020/8/18

See List of Professors in Juan García-Revilla University(Universidad de Sevilla)

Co-Authors

academic-engine